Literature DB >> 20579764

NALP3 is not necessary for early protection against experimental tuberculosis.

Kerstin Walter1, Christoph Hölscher, Jürg Tschopp, Stefan Ehlers.   

Abstract

In vitro, Toll-like receptors (TLR)2, 4 and 9 as well as NOD-like receptor 2 critically determine macrophage responses to Mycobacterium tuberculosis (Mtb) infection. However, in low-dose experimental murine tuberculosis, single or multiple deficiencies in TLRs 2, 4, 9 or NOD2 have little, if any, impact on early mycobacterial growth containment, granuloma formation and survival. Here, we analyzed the relevance of NALP3, one component of the danger-signaling inflammasome, for (i) Mtb-induced cytokine secretion in vitro and in vivo, (ii) restriction of Mtb replication in infected organs and (iii) granuloma formation. In the absence of functional NALP3, there was no IL-1beta and IL-18 production in Mtb-infected dendritic cells and macrophages in vitro, whereas secretion of IL-1alpha, IL-12p40 and TNF remained unaffected. After three weeks of infection, NALP3-deficient as well as IL-18-deficient mice were as capable as wildtype mice of restricting Mtb loads at a plateau level within well-differentiated granulomas. In conclusion, despite its involvement in cytokine processing, NALP3 is not essential for induction of protective immunity to Mtb. Copyright 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579764     DOI: 10.1016/j.imbio.2010.05.015

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  25 in total

Review 1.  The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.

Authors:  P Menu; J E Vince
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

Review 2.  Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.

Authors:  Anca Dorhoi; Stefan H E Kaufmann
Journal:  Semin Immunopathol       Date:  2015-10-05       Impact factor: 9.623

3.  Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Daniel L Barber; Sara Hieny; Carl G Feng; Patricia Caspar; Sandy Oland; Siamon Gordon; Alan Sher
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 4.  Cytokine and lipid mediator networks in tuberculosis.

Authors:  Katrin D Mayer-Barber; Alan Sher
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 5.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

Review 6.  Role of innate cytokines in mycobacterial infection.

Authors:  A M Cooper; K D Mayer-Barber; A Sher
Journal:  Mucosal Immunol       Date:  2011-03-23       Impact factor: 7.313

Review 7.  Interaction of Mycobacterium tuberculosis with host cell death pathways.

Authors:  Lalitha Srinivasan; Sarah Ahlbrand; Volker Briken
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-26       Impact factor: 6.915

Review 8.  Cytokines in the balance of protection and pathology during mycobacterial infections.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 9.  How Inflammasomes Inform Adaptive Immunity.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.